Potential of resveratrol in anticancer and anti-inflammatory therapy

Nutrition Reviews

Volumn 66, Issue 8, 2008, Pages 445-454

  Udenigwe, Chibuike C ^b   Ramprasath, Vanu R ^a   Aluko, Rotimi E ^a,b   Jones, Peter J H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anti inflammatory; Anticancer; Polyphenol; Resveratrol

Indexed keywords

PICEID; RESVERATROL;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LUNG CARCINOMA; NEPHROTOXICITY; NONHUMAN; PROSTATE ADENOCARCINOMA; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ARACHIS HYPOGAEA; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE INHIBITORS; FRUIT; HUMANS; PHYTOTHERAPY; STILBENES; VITIS; WINE;

ANIMALIA; CURCUMA LONGA; VITACEAE;

EID: 48349106315     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00076.x     Document Type: Article

References (59)

1. Kris-etherton PM, Hecker KD, Bonanome A, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002 113 (Suppl S71 S88.
2. Athar M, Back JH, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007 224 : 274 283.
3. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potentials. Front Biosci. 2007 12 : 4839 4854.
4. Holme AL, Pervaiz S. Resveratrol in cell fate decisions. J Bioenerg Biomembr. 2007 39 : 59 63.
5. King RE, Bomser JA, Min DB. Bioactivity of resveratrol. Compreh Rev Food Sci Food Safety. 2006 5 : 65 70.
6. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 2007 6 : 168 173.
7. Surh YJ, Kundu JK. Resveratrol as an anti-inflammatory agent. In : Aggarwal BB, Shishodia S, eds. Resveratrol in Health and Disease. CRC Press 2006 : 601 617.
8. Signorelli P, Ghidoni R. Resveratrol as an antiproliferative agent for cancer. In : Aggarwal BB, Shishodia S, eds. Resveratrol in Health and Disease. CRC Press 2006 : 57 83.
9. Pervaiz S, Holme AL. Mechanism of apoptosis by resveratrol. In : Aggarwal BB, Shishodia S, eds. Resveratrol in Health and Disease. CRC Press 2006 : 85 104.
10. Sanders TH, McMichael RW, Hendrix KW. Occurrence of resveratrol in edible peanuts. J Agric Food Chem. 2000 48 : 1243 1246.
11. Burns J, Yokota T, Ashihara H, Lean MEJ, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002 50 : 3337 3340.
12. Sobolev VS, Cole RJ. trans-Resveratrol content in commercial peanuts and peanut products. J Agric Food Chem. 1999 47 : 1435 1439.
13. Wang Y, Catana F, Yang Y, Roderick R, van Breemen RB. An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem. 2002 50 : 431 435.
14. Lyons MM, Yu C, Toma RB, et al. Resveratrol in raw and baked blueberries and bilberries. J Agric Food Chem. 2003 51 : 5867 5870.
15. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006 5 : 493 506.
16. Buiarelli F, Coccioli F, Jasionowska R, Merolle M, Terracciano A. Analysis of some stilbenes in Italian wines by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom, 2007 21 : 2955 2964.
17. Mercolini L, Saracino MA, Bugamelli F, et al. HPLC-F analysis of melatonin and resveratrol isomers in wine using an SPE procedure. J Sep Sci, 2008 31 : 1007 1014.
18. LeBlanc MR. Cultivar, juice extraction, ultra violet irradiation and storage influence the stilbene content of muscadine grape (Vitis rotundifolia Michx.). Ph.D. Thesis, Louisiana State University and Agricultural and Mechanical College, Baton Rouge, LA, USA, 2006.
19. Pedras MSC, Ahiahonu PWK. Metabolism and detoxification of phytoalexins and analogues by phytopathogenic fungi. Phytochemistry. 2005 66 : 391 411.
20. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French Paradox for coronary heart disease. Lancet. 1992 339 : 1523 1526.
21. de Lange DW. From red wine to polyphenols and back: a journey through the history of the French Paradox. Thromb Res. 2007 119 : 403 406.
22. Jang M, Cai L, Udeani CO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997 275 : 218 220.
23. Soleas GJ, Grass L, Josephy DP, Goldberg DM, Diamandis EP. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem. 2006 39 : 492 497.
24. Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005 49 : 472 481.
25. Wenzel E, Soldo T, Erbersdobler H, Somoza V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res. 2005 49 : 482 494.
26. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003 72 : 2219 2233.
27. Boocock DJ, Faust GES, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers. 2007 16 : 1246 1252.
28. 3H]trans-resveratrol in rat tissues following oral administration. Br J Nutr. 2006 96 : 62 70.
29. Vitaglione P, Sforza S, Galaverna G, et al. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res. 2005 49 : 495 504.
30. van Ginkel PR, Sareen D, Subramanian L, et al. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res. 2007 13 : 5162 5169.
31. Trincheri NF, Nicotra G, Follo C, Castino R, Isidoro C. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis. 2007 28 : 922 931.
32. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem. 2007 282 : 19385 19398.
33. Golkar L, Ding XZ, Ujiki MB, et al. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 138 : 163 169.
34. Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007 109 : 2293 2302.
35. Tang HT, Shih A, Cao J, Davis FB, Davis PL, Lin HY. Resveratrol-induced cyclooxygenase-2 apoptosis in human breast cancer cells. Mol Cancer Ther. 2006 5 : 2034 2042.
36. Sun C, Hu Y, Liu X, et al. Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogen. 2006 165 : 9 19.
37. Hwang JT, Kwak DW, Lin SK, Kim HM, Kim YM, Park OJ. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signalling pathway. Ann NY Acad Sci. 2007 1095 : 441 448.
38. Cecchinato V, Chiaramonte R, Nizzardo M, et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells. Biochem Pharmacol. 2007 74 : 1568 1577.
39. Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellón EA. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostrate cancer-derived cell lines. J Androl. 2007 28 : 282 293.
40. Busquets S, AmEtller E, Fuster G, et al. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett. 2007 245 : 144 148.
41. Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA. Resveratrol suppresses prostrate cancer progression in transgenic mice. Carcinogenesis. 2007 28 : 1946 1953.
42. Burgering BM, Kops GJ. Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 2002 27 : 352 360.
43. Shankar S, Siddiqui I, Srivastava RK. Molecular mechanisms of resveratrol (3,4′,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostrate cancer cells. Mol Cell Biochem. 2007 304 : 273 285.
44. Gehm BD, McAndrews JM, Chien P, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 1997 94 : 14138 14143.
45. Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and angiogenesis in human breast cancer xenografts in vivo. Cancer Lett. 2006 231 : 113 122.
46. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. Eur J Cancer Prev. 2005 14 : 139 142.
47. El Mobrouk M, Ahmad R, Sylvester J, Zafarullah M. Curcumin, nordihydroguiaretic acid, quercetin and resveratrol inhibit interleukin-1- induced ADAMTS-4 (aggrecanase-1) gene expression in articular chondrocytes: natural products as potential arthritic agents. Pharmacology online. 2006 3 : 601 610.
48. Candelario-Jalil E, Pinheiro De Oliveira AC, Gräf S, et al. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J Neuroinflamm. 2007 4 : 25.
49. Kim YA, Kim GY, Park KY, Choi YH. Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysacharide-activated C6 microglia. J Med Food. 2007 10 : 218 224.
50. Sharma S, Chopra K, Kulkarni SK, Agrewala JN. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol. 2007 147 : 155 163.
51. Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P. Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptors and estrogen receptors. Mol Pharmacol. 2007 72 : 1508 1521.
52. Kundu JK, Shin YK, Kim SH, Surh YJ. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity. Carcinogenesis. 2006 27 : 1465 1474.
53. de Jesus Soares T, Volpini RA, Francescato HDC, Costa RS, Da Silva CGA, Coimbra TM. Effects of resveratrol on glycerol-induced renal injury. Life Sci. 2007 81 : 647 656.
54. Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr. 2002 132 : 257 260.
55. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol Sci. 2004 82 : 614 619.
56. Resveratrol in treating patients with colorectal cancer that can be removed by surgery. Available at: http://clinicaltrials.gov/ct2/show/ NCT00433576. Accessed 8 December 2007.
57. Resveratrol for patients with colon cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT00256334. Accessed 8 December 2007.
58. Phase I biomarker study of dietary grape-derived low dose resveratrol for colon cancer prevention. Available at: http://clinicaltrials.gov/ct2/show/ NCT00578396. Accessed 14 April 2008.
59. Dietary intervention in follicular lymphoma. Available at: http://clinicaltrials.gov/ct2/show/NCT00455416. Accessed 8 December 2007.